MESO mesoblast.com: יחס שווי פעילות להכנסות

The development of Mesoblast Limited (MESO) is directly linked to FDA verdicts and the test results of new drugs. On GURU.Markets, the EV/Sales history clearly demonstrates this volatility, with the value stabilizing at 12267.15. Business stability relies on patents in the field of regenerative medicine and close cooperation with contract manufacturing organizations for the production of cell-based products.
פילוחי מדדים פיננסיים ומדדי שוק עבור Mesoblast Corp (MESO)

The seamless delivery of cellular materials through specialized logistics channels ensures the stability of Mesoblast Limited (MESO) operational flows. This metric compares the total enterprise value, including net debt, with sales volume, allowing for an assessment of resource monetization efficiency without distortions from debt load; therefore, analyzing the trend of the company's enterprise value-to-revenue ratio helps investors timely identify whether the asset is overbought or undervalued.